Short interest for Paymentus Holdings gives investors a sense of the degree to which investors are betting on the decline of Paymentus Holdings's stock. Short interest data is updated every two weeks.

Paymentus Holdings Stock (NYSE:PAY), Short Interest Report

Paymentus Holdings

Paymentus Holdings Inc provides electronic bill presentment and payment services, enterprise customer communication and self-service revenue management to billers and financial institutions through a Software-as-a-Service, (SaaS), secure, omni-channel technology platform. The platform integrates into a biller's core financial and operating systems to provide flexible and secure access to payment processing of credit cards, debit cards, eChecks and digital wallets across a number of channels including online, mobile, IVR, call center, chatbot and voice-based assistants. The Company generates revenue from payment transaction fees processed through the Company's platform. The fees are generated as a percentage of transaction value or a specified fee per transaction.

News

Penny Stocks

Small Cap

Intraday Update

Markets

Movers

Trading Ideas

ALIT

ANVS

CLSK

CVNA

DRCT

DWAC

IBRX

LIVN

LVWR

MARA

MODG

SKIN

SRAD

TSHA

WULF

U.S. stocks were mixed, with the Dow Jones index gaining around 0.1% on Wednesday.

Sportradar Group Posts Upbeat Earnings, Joins Kingsoft Cloud, Braskem And Other Big Stocks Moving Higher On Wednesday

Short Ideas

Pre-Market Outlook

COIN

TOST

As of March 13, 2024, four stocks in the financial sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

Top 4 Financial Stocks That May Collapse This Quarter

Wall Street Bear AI

Analyst Color

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Earnings Beats

Earnings Misses

Equities

Sector ETFs

Broad U.S. Equity ETFs

Commodities

Analyst Ratings

Tech

ETFs

CHPT

CRWD

SPDR Dow Jones Industrial Average ETF Trust

GTLB

NVDA

NYCB

ROST

SFIX

SOFI

iShares Trust Barclays 20+ Year Treasury Bond Fund

TSLA

Wall Street indices in the red as tech stocks plunge. Tesla down 4%, Apple down 2.7%. ISM Services PMI lower than expected. Bitcoin hits record high before dropping 6%. Treasury yields down, gold up. NYCB up 17%, Target up 12%, Albemarle down 11%, GitLab down 22.4%, and SoFi down.

Bears Prowl Wall Street As Magnificent 7 Tumble; Bitcoin Sinks After Record High: What&#39;s Driving Markets Tuesday?

Paymentus Holdings, Inc. Class A Common Stock

Paymentus Holdings Inc

TenX

Paycom Software Inc

Paid Inc

Payoneer Global Inc

PaySign Inc

Paychex Inc

Goldman Sachs analyst Will Nance maintains Paymentus Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PAY#NYSE">PAY</a>) with a Neutral and raises the price target from $20 to $22.5.

Price Target

Goldman Sachs Maintains Neutral on Paymentus Holdings, Raises Price Target to $22.5

Paymentus Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PAY#NYSE">PAY</a>) has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $19.5, with a high estimate of $22.00 and a low estimate of $17.00. Surpassing the previous average price target of $18.33, the current average has increased by 6.38%.
<img src="https://www.benzinga.com/files/images/story/2024/1712923236_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
The perception of Paymentus Holdings by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>David Koning</td>
<td>Baird</td>
<td>Raises</td>
<td>Neutral</td>
<td>$22.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Tien-Tsin Huang</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$19.00</td>
<td>$17.00</td>
</tr>
<tr>
<td>Will Nance</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Neutral</td>
<td>$20.00</td>
<td>$18.00</td>
</tr>
<tr>
<td>Andrew Bauch</td>
<td>Wells Fargo</td>
<td>Announces</td>
<td>Equal-Weight</td>
<td>$17.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Paymentus Holdings. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Paymentus Holdings compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Paymentus Holdings's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
To gain a panoramic view of Paymentus Holdings's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/PAY/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Paymentus Holdings analyst ratings.</a>
<h2>Get to Know Paymentus Holdings Better</h2>
Paymentus Holdings Inc provides electronic bill presentment and payment services, enterprise customer communication and self-service revenue management to billers and financial institutions through a Software-as-a-Service, (SaaS), secure, omni-channel technology platform. The platform integrates into a biller's core financial and operating systems to provide flexible and secure access to payment processing of credit cards, debit cards, eChecks and digital wallets across a number of channels including online, mobile, IVR, call center, chatbot and voice-based assistants. The Company generates revenue from payment transaction fees processed through the Company's platform. The fees are generated as a percentage of transaction value or a specified fee per transaction.
<h3>Key Indicators: Paymentus Holdings's Financial Health</h3>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
Revenue Growth: Paymentus Holdings's revenue growth over a period of 3 months has been noteworthy. As of 31 December, 2023, the company achieved a revenue growth rate of approximately 24.68%. This indicates a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Financials sector.
Net Margin: Paymentus Holdings's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of 5.71%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Paymentus Holdings's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of 2.22%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): Paymentus Holdings's ROA excels beyond industry benchmarks, reaching 1.89%. This signifies efficient management of assets and strong financial health.
Debt Management: Paymentus Holdings's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.02.
<h2>The Significance of Analyst Ratings Explained</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Expert Outlook: Paymentus Holdings Through The Eyes Of 4 Analysts

Baird analyst David Koning maintains Paymentus Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PAY#NYSE">PAY</a>) with a Neutral and raises the price target from $20 to $22.

Baird Maintains Neutral on Paymentus Holdings, Raises Price Target to $22

<h3>Companies Reporting Before The Bell</h3>
&bull; Mach Natural Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MNR#NYSE">MNR</a>) is projected to report quarterly earnings at $0.92 per share on revenue of $213.43 million.
&bull; Sharps Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STSS#NASDAQ">STSS</a>) is expected to report earnings for its fourth quarter.
&bull; Sachem Cap (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SACH#AMEX">SACH</a>) is projected to report quarterly earnings at $0.11 per share on revenue of $16.58 million.
&bull; Enservco (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ENSV#AMEX">ENSV</a>) is projected to report quarterly loss at $0.05 per share on revenue of $6.60 million.
&bull; NexGel (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXGL#NASDAQ">NXGL</a>) is likely to report quarterly loss at $0.11 per share on revenue of $1.38 million.
&bull; Milestone Scientific (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MLSS#AMEX">MLSS</a>) is likely to report earnings for its fourth quarter.
&bull; SPAR Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGRP#NASDAQ">SGRP</a>) is estimated to report earnings for its fourth quarter.
&bull; Escalade (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ESCA#NASDAQ">ESCA</a>) is estimated to report earnings for its fourth quarter.
&bull; LogicMark (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGMK#NASDAQ">LGMK</a>) is likely to report quarterly loss at $1.73 per share on revenue of $2.28 million.
&bull; Jaguar Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JAGX#NASDAQ">JAGX</a>) is projected to report earnings for its fourth quarter.
&bull; Crown ElectroKinetics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRKN#NASDAQ">CRKN</a>) is expected to report earnings for its fourth quarter.
&bull; LM Funding America (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LMFA#NASDAQ">LMFA</a>) is estimated to report earnings for its fourth quarter.
&bull; DecisionPoint Sys (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/DPSI#AMEX">DPSI</a>) is expected to report earnings for its fourth quarter.
&bull; Edible Garden AG (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EDBL#NASDAQ">EDBL</a>) is estimated to report earnings for its fourth quarter.
&bull; Laser Photonics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LASE#NASDAQ">LASE</a>) is expected to report earnings for its fourth quarter.
&bull; Terran Orbital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLAP#NYSE">LLAP</a>) is estimated to report quarterly loss at $0.20 per share on revenue of $32.81 million.
&bull; Sigma Lithium (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGML#NASDAQ">SGML</a>) is expected to report quarterly earnings at $0.18 per share on revenue of $105.82 million.
&bull; Vislink Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VISL#NASDAQ">VISL</a>) is estimated to report earnings for its fourth quarter.
&bull; Nano X Imaging (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NNOX#NASDAQ">NNOX</a>) is projected to report quarterly loss at $0.30 per share on revenue of $2.82 million.
&bull; Ondas Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONDS#NASDAQ">ONDS</a>) is estimated to report quarterly loss at $0.14 per share on revenue of $4.27 million.
&bull; TriSalus Life Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLSI#NASDAQ">TLSI</a>) is projected to report quarterly loss at $0.69 per share on revenue of $5.45 million.
&bull; Venus Concept (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERO#NASDAQ">VERO</a>) is projected to report quarterly loss at $1.18 per share on revenue of $22.45 million.
<h3>Companies Reporting After The Bell</h3>
&bull; BurgerFi International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BFI#NASDAQ">BFI</a>) is expected to report quarterly loss at $0.19 per share on revenue of $40.00 million.
&bull; AST SpaceMobile (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASTS#NASDAQ">ASTS</a>) is expected to report earnings for its fourth quarter.
&bull; PVH (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PVH#NYSE">PVH</a>) is expected to report quarterly earnings at $3.53 per share on revenue of $2.42 billion.
&bull; VirTra (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VTSI#NASDAQ">VTSI</a>) is projected to report quarterly earnings at $0.15 per share on revenue of $9.37 million.
&bull; Motorsport Games (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSGM#NASDAQ">MSGM</a>) is estimated to report earnings for its fourth quarter.
&bull; Yield10 Bioscience (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YTEN#NASDAQ">YTEN</a>) is estimated to report quarterly loss at $0.30 per share on revenue of $30 thousand.
&bull; OMNIQ (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OMQS#NASDAQ">OMQS</a>) is likely to report quarterly loss at $0.26 per share on revenue of $16.35 million.
&bull; FlexShopper (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FPAY#NASDAQ">FPAY</a>) is projected to report quarterly loss at $0.25 per share on revenue of $30.51 million.
&bull; Stryve Foods (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNAX#NASDAQ">SNAX</a>) is estimated to report quarterly loss at $1.96 per share on revenue of $5.01 million.
&bull; Air Industries (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AIRI#AMEX">AIRI</a>) is expected to report quarterly loss at $0.34 per share on revenue of $12.40 million.
&bull; Eastside Distilling (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EAST#NASDAQ">EAST</a>) is expected to report quarterly loss at $0.90 per share on revenue of $3.68 million.
&bull; BIO-key Intl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKYI#NASDAQ">BKYI</a>) is expected to report earnings for its fourth quarter.
&bull; SKYX Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SKYX#NASDAQ">SKYX</a>) is likely to report quarterly loss at $0.08 per share on revenue of $21.12 million.
&bull; Omeros (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OMER#NASDAQ">OMER</a>) is projected to report earnings for its fourth quarter.
&bull; Natural Gas Services Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NGS#NYSE">NGS</a>) is estimated to report quarterly earnings at $0.06 per share on revenue of $30.30 million.
&bull; TOMI Environmental Solns (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TOMZ#NASDAQ">TOMZ</a>) is expected to report quarterly loss at $0.01 per share on revenue of $2.86 million.
&bull; Canoo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOEV#NASDAQ">GOEV</a>) is likely to report quarterly loss at $1.77 per share on revenue of $700 thousand.
&bull; GSE Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GVP#NASDAQ">GVP</a>) is likely to report quarterly loss at $0.81 per share on revenue of $12.07 million.
&bull; Acorda Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACOR#NASDAQ">ACOR</a>) is likely to report earnings for its fourth quarter.
&bull; Protagenic Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTIX#NASDAQ">PTIX</a>) is projected to report earnings for its fourth quarter.
&bull; SHF Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHFS#NASDAQ">SHFS</a>) is likely to report earnings for its fourth quarter.
&bull; Ideanomics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IDEX#NASDAQ">IDEX</a>) is likely to report earnings for its fourth quarter.
&bull; American Strategic (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NYC#NYSE">NYC</a>) is estimated to report quarterly loss at $0.07 per share on revenue of $16.53 million.
&bull; Zomedica (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ZOM#AMEX">ZOM</a>) is expected to report earnings for its fourth quarter.
&bull; Microvast Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MVST#NASDAQ">MVST</a>) is estimated to report quarterly loss at $0.07 per share on revenue of $94.43 million.
&bull; Paymentus Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PAY#NYSE">PAY</a>) is projected to report quarterly earnings at $0.11 per share on revenue of $50.27 million.
&bull; IZEA Worldwide (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IZEA#NASDAQ">IZEA</a>) is projected to report quarterly loss at $0.07 per share on revenue of $10.00 million.
&bull; Duos Technologies Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DUOT#NASDAQ">DUOT</a>) is expected to report quarterly loss at $0.25 per share on revenue of $3.00 million.
&bull; Pioneer Power Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PPSI#NASDAQ">PPSI</a>) is expected to report quarterly earnings at $0.01 per share on revenue of $10.89 million.
This article was generated by Benzinga&#39;s automated content engine and reviewed by an editor.

Earnings

ACOR

AIRI

ASTS

BKYI

CRKN

DPSI

DUOT

EAST

EDBL

ENSV

ESCA

FPAY

GOEV

IDEX

IZEA

JAGX

LASE

LGMK

LLAP

LMFA

MLSS

MSGM

MVST

NNOX

NXGL

OMER

OMQS

ONDS

PPSI

PTIX

SACH

SGML

SGRP

SHF Holdings, Inc. - Class A Common Stock

SHFS

SKYX

SNAX

STSS

TLSI

TOMZ

VERO

VISL

VTSI

YTEN

Earnings Scheduled For April 1, 2024

U.S. stocks were mixed, with the Dow Jones index gaining around 0.1% on Wednesday.
Shares of Sportradar Group AG (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/srad#NASDAQ">SRAD</a>) rose sharply during Wednesday&rsquo;s session after the company reported better-than-expected fourth-quarter results and authorized a $200 million <a href="https://www.benzinga.com/quote/SRAD/earnings">share repurchase program</a>.
Sportradar posted quarterly earnings of 8 cents per share, beating market estimates of 4 cents per share. The company&rsquo;s quarterly sales came in at $271.88 million, beating market expectations of $271.46 million, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Sportradar Group shares jumped 10.7% to $11.17 on Wednesday.
Here are some other big stocks recording gains in today&rsquo;s session.
<ul>
<li>Annovis Bio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/anvs#NASDAQ">ANVS</a>) shares surged 25.6% to $11.21 after the company announced the completion of data cleaning for its Phase 2/3 study of Buntanetap in patients with mild to moderate Alzheimer&#39;s disease, with Topline efficacy data expected in April.</li>
<li>Taysha Gene Therapies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tsha#NASDAQ">TSHA</a>) gained 23% to $2.7650 after the company reported a year-over-year increase in FY23 EPS results.</li>
<li>Digital World Acquisition Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dwac#NASDAQ">DWAC</a>) climbed 18.1% to $43.00.</li>
<li>TeraWulf Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wulf#NASDAQ">WULF</a>) rose 18% to $2.0297 amid a rise in Bitcoin.</li>
<li>Kingsoft Cloud Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/kc#NASDAQ">KC</a>) jumped 16.7% to $3.7600 after the company reported a fourth-quarter fiscal 2023 revenue of $242.6 million, marginally beating the consensus of $242.4 million.</li>
<li>Direct Digital Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/drct#NASDAQ">DRCT</a>) climbed 16.5% to $31.70.</li>
<li>Braskem S.A. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bak#NYSE">BAK</a>) climbed 12.7% to $10.13 after the company on Tuesday reported fourth-quarter financial results.</li>
<li>LiveWire Group, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/lvwr#NYSE">LVWR</a>) surged 12.5% to $7.29.</li>
<li>Pagaya Technologies Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pgy#NASDAQ">PGY</a>) gained 12.4% to $10.25.</li>
<li>LivaNova PLC (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/livn#NASDAQ">LIVN</a>) climbed 12.3% to $56.55 after the company announced its OSPREY clinical study, Treating Obstructive Sleep Apnea Using Targeted Hypoglossal Nerve Stimulation achieved a &#39;positive predictive outcome&#39; and will conclude enrollment earlier than anticipated.</li>
<li>Topgolf Callaway Brands Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/modg#NYSE">MODG</a>) rose 11.8% to $16.11 following a Chosun Daily report suggesting the company is up for sale.</li>
<li>Alight, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/alit#NASDAQ">ALIT</a>) gained 11.5% to $9.85 after the company announced an agreement to sell its Payroll &amp; Professional Services business for up to $1.2 billion.</li>
<li>ImmunityBio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ibrx#NASDAQ">IBRX</a>) gained 10.5% to $6.00.</li>
<li>The Beauty Health Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/skin#NASDAQ">SKIN</a>) climbed 9.3% to $4.3050.</li>
<li>CleanSpark, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/clsk#NASDAQ">CLSK</a>) rose 7.5% to $17.72.</li>
<li>Marathon Digital Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mara#NASDAQ">MARA</a>) gained 7.5% to $20.77 amid a rise in Bitcoin.</li>
<li>Paymentus Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pay#NYSE">PAY</a>) climbed 6.8% to $23.92.</li>
<li>Spirit AeroSystems Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/spr#NYSE">SPR</a>) rose 6.7% to $35.19.</li>
<li>Carvana Co (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cvna#NYSE">CVNA</a>) climbed 5.3% to $83.07.</li>
<li>Chipotle Mexican Grill, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cmg#NYSE">CMG</a>) gained 5.1% to $2,941.41 after company&#39;s board approved a 50-for-1 split of common shares.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/03/37839587/disney-jpmorgan-and-more-cnbcs-final-trades"> Disney, JPMorgan And More: CNBC&#39;s &#39;Final Trades&#39;</a>

Raymond James analyst John Davis downgrades Paymentus Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PAY#NYSE">PAY</a>) from Outperform to Market Perform.

Downgrades

Raymond James Downgrades Paymentus Holdings to Market Perform

As of March 13, 2024, four stocks in the financial sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
The RSI is a momentum indicator, which compares a stock&#39;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#39;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the <a href="https://www.benzinga.com/topic/rsi"> RSI is above 70</a>, according to <a href="https://pro.benzinga.com/"> Benzinga Pro</a>.
Here&rsquo;s the latest list of major overbought players in this sector.
<h3>Paymentus Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pay#NYSE">PAY</a>)</h3>
<ul>
<li>On March 4, Paymentus reported quarterly earnings of 11 cents per share which beat the analyst consensus estimate of 7 cents per share. &ldquo;Paymentus again reported quarterly results that exceeded our original expectations as revenue rose 24.7%, contribution profit grew 22.7% and adjusted EBITDA was up 95.4% year-over-year. We also ended the year on solid footing with a strong backlog, which we believe leaves us well positioned for continued growth in 2024,&rdquo; said Dushyant Sharma, CEO of Paymentus Holdings. The company&rsquo;s stock gained around 19% over the past five days and has a <a href="https://www.benzinga.com/quote/PAY">52-week high of $24.00 </a>.</li>
<li>RSI Value: 82.24</li>
<li>PAY Price Action: Shares of Paymentus gained 14.9% to close at $23.93 on Tuesday.</li>
</ul>
<h3>Toast, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tost#NYSE">TOST</a>)</h3>
<ul>
<li>On Feb. 15, Toast reported quarterly losses of 7 cents per share, which beat the analyst consensus estimate of losses of 11 cents per share by 36.36%. The company&rsquo;s board of directors also authorized a share repurchase program of up to $250 million of its Class A common stock. The company&rsquo;s stock gained around 29% over the past month and <a href="https://www.benzinga.com/quote/TOST"> has a 52-week high </a> of $27.00.</li>
<li>RSI Value: 72.43</li>
<li>TOST Price Action: Shares of Toast gained 1.4% to close at $25.00 on Tuesday.</li>
</ul>
<h3>Coinbase Global, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/coin#NASDAQ">COIN</a>)</h3>
<ul>
<li>On March 12, Coinbase Global announced a proposed private offering of $1 billion of convertible senior notes due 2030. The company&rsquo;s stock gained around 82% over the past month has a <a href="https://www.benzinga.com/quote/COIN"> 52-week high </a> of $271.65.</li>
<li>RSI Value: 77.65</li>
<li>COIN Price Action: Shares of Coinbase Global gained 0.8% to close at $256.14 on Tuesday.</li>
</ul>
<h3>Lloyds Banking Group plc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/lyg#NYSE">LYG</a>)</h3>
<ul>
<li>On Feb. 22, Lloyds Banking Group reported a year-over-year increase in fourth-quarter adjusted EPS results. The company&rsquo;s stock jumped around 24% over the past month and has a 52-week high is $2.53.</li>
<li>RSI Value: 79.27</li>
<li>LYG Price Action: Shares of Lloyds Banking rose 0.4% to close at $2.51 on Tuesday.</li>
</ul>
&nbsp;
Read More: <a href="https://www.benzinga.com/news/earnings/24/03/37641240/investor-sentiment-improves-following-inflation-data-dow-jumps-over-200-points"> Investor Sentiment Improves Following Inflation Data, Dow Jumps Over 200 Points </a>

WIIM

Paymentus Holdings shares are trading higher. The stock may be gaining on continued strength after the company last week posted better-than-expected fourth-quarter financial results.

JP Morgan analyst Tien-Tsin Huang maintains Paymentus Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PAY#NYSE">PAY</a>) with a Neutral and raises the price target from $17 to $19.

JP Morgan Maintains Neutral on Paymentus Holdings, Raises Price Target to $19

Volatility knocked on the doors of Wall Street on Tuesday, with major indices all in the red during midday trading as mega-cap <a href="https://www.benzinga.com/markets">tech stocks plunged simultaneously.</a>
All the Magnificent Seven names experienced losses. Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) nosedived over 4%, while Apple Inc. (NASDAQ AAPL) shed 2.7%, marking its fifth consecutive session of losses. This decline followed a report indicating a 24% drop in iPhone sales in China during the first six weeks of 2024.
On the data front, signals were mixed. The ISM Services PMI reported a lower-than-expected expansion in February, and factory orders <a href="https://www.benzinga.com/economics/macro-economic-events/24/03/37486465/service-sector-expands-for-14th-consecutive-month-contrasted-by-largest-factory-o">sharply declined in January.</a>
Elsewhere, Bitcoin continued to seize headlines. The largest cryptocurrency surged past all-time highs above $69,000 before plunging by 6% just minutes after reaching the milestone, reflecting some profit-taking behavior among investors.
Meanwhile, Treasury yields experienced a modest downturn as investors pondered the increasing likelihood of Federal Reserve interest rate cuts for the first half of 2024. This ignited gains in long-dated Treasuries, with the iShares 20+ Year Treasury Bond ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLT#NASDAQ">TLT</a>) up 1.2%.
Gold rallied for the fifth consecutive day, reaching an intraday high of $2,141/oz, effectively flirting with the all-time highs reached last December at $2,146.
<h2 class="wp-block-heading">Tuesday&#8217;s Performance In Major US Indices, ETFs</h2>
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>1-Day %Chg</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2,047.85</td>
<td>-0.4%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>38,678.32</td>
<td>-0.8%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>5,085.84</td>
<td>-0.9%</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>17,913.42</td>
<td>-1.7%</td>
</tr>
<tr>
<td>CBOE VIX</td>
<td>14.38</td>
<td>6.6%</td>
</tr>
</tbody>
</table>
</figure>
The&nbsp;SPDR S&amp;P 500 ETF Trust&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) fell 0.9% to $508.02, the&nbsp;SPDR Dow Jones Industrial Average (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>) fell 0.7% to $387.42 and the tech-heavy&nbsp;Invesco QQQ Trust&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) tumbled 1.7% to $436.45, according to&nbsp;<a href="https://pro.benzinga.com/dashboard">Benzinga Pro data</a>.&nbsp;
The&nbsp;Energy&nbsp;Select Sector SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>), was the outperformer, up by 1.3%, while the&nbsp;Technology Select Sector SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>) sharply underperformed, down 2.4%.&nbsp;
<h2 class="wp-block-heading">Tuesday&#8217;s Stock Movers</h2>
<ul>
<li>New York Community Bancorp, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NYCB#NYSE">NYCB</a>) rose 17% after KBW analysts noted plans to sell mortgage-servicing rights, boosting capital to bolster its balance sheet and mitigate potential real estate loan losses.</li>
<li>Target Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TGT#NYSE">TGT</a>) rose over 12% after better-than-expected quarterly results. </li>
<li>Albemarle Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALB#NYSE">ALB</a>) declined by more than 11% following a nearly 7% drop on Tuesday, triggered by the company&#8217;s disclosure of plans to raise capital through a $2 billion issuance of depositary shares.</li>
<li>GitLab Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTLB#NASDAQ">GTLB</a>) shares tumbled 22.4% to $57.80 after the company issued FY25 earnings guidance below estimates.</li>
<li>Other companies reacting to earnings were Paymentus Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PAY#NYSE">PAY</a>) (up over 24%) and Stitch Fix, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFIX#NASDAQ">SFIX</a>) (down over 19%).</li>
<li>SoFi Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOFI#NASDAQ">SOFI</a>) plummeted over 13% as the fintech company unveiled intentions to offer $750 million of convertible senior notes due in 2029, thereby heightening dilution risks for shareholders.</li>
<li>Nordstrom, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JWN#NYSE">JWN</a>), Ross Stores, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROST#NASDAQ">ROST</a>), Box, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BOX#NYSE">BOX</a>), CrowdStrike Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) and ChargePoint Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHPT#NYSE">CHPT</a>) will report after the close.</li>
</ul>
Read now: <a href="https://www.benzinga.com/markets/cryptocurrency/24/03/37470492/bitcoin-hovers-around-new-all-time-high-experts-eye-bullish-future-a-perfect-setup">Bitcoin Hovers Around New All-Time High, Experts Eye Bullish Future: &#8216;A Perfect Setup&#8217;</a>
Image created using artificial intelligence with Midjourney.

Bears Prowl Wall Street As Magnificent 7 Tumble; Bitcoin Sinks After Record High: What's Driving Markets Tuesday?

Paymentus Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PAY#NYSE">PAY</a>) shares are trading higher Tuesday after the company posted better-than-expected <a href="https://www.benzinga.com/news/earnings/24/03/37469002/paymentus-stock-climbs-after-q4-heres-why">fourth-quarter financial results</a>.
The Details:
The company reported quarterly earnings of 11 cents per share, which beat the analyst consensus estimate of 7 cents per share Monday after the bell.  
Quarterly sales clocked in at $164.8 million which beat the analyst consensus estimate of $157.416 million and is a 24.68% increase over last year. The company processed 124.8 million transactions in the quarter, up 28.4% from last year.
Goldman Sachs maintained its Neutral rating on the stock and raised its price target from $18 to $20 following the print. The firm highlighted the company&#8217;s expansion into larger billers and increased contribution from newer verticals and expects Paymentus to deliver strong performance as the payments market shifts toward biller direct models.
Related News: <a href="https://www.benzinga.com/news/24/03/37467155/why-new-york-community-bancorp-stock-is-tumbling">Why New York Community Bancorp Stock Is Tumbling</a>
<h2 class="wp-block-heading">PAY Stock Forecast 2030:</h2>
Predicting the future in stock prices over long periods of time is challenging. Wall Street analysts use complex models that take into account interest rates, economic growth, competitive advantages, management teams and historical profitability, among a host of other factors.
If, as an investor, you want to assume most of the major factors remain stable, you can use trend analysis as a helpful tool. Using a longer term trend line or historical performance of the stock, you can aim to forecast a stock's annual rate of return.
 For Paymentus Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PAY#NYSE">PAY</a>), over the past 5 years, it's annualized stock performance is -10.59%, and if you assume that trend continues for another 5 years, you can expect a stock to trade at $11.46.
Using a trend line (see how to <a href="https://www.benzinga.com/23/01/30335939/a-guide-on-how-to-identify-trend-reversals">perform this function here</a>), If you choose to use a trend line, connect your two points and look into the future to the point in time in which you're curious. Once you've identified that stock price, you may want to consider what type of conditions would need to exist for the stock to justify the share price &#8211; be it an outside influence or managerial decision making.
PAY Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Paymentus shares are up 27.7% at $20.88 at the time of publication.
Image: Mohamed Hassan from Pixabay

Why Paymentus Stock Is Higher Today

Shares of SOPHiA GENETICS SA (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/soph#NASDAQ">SOPH</a>) fell sharply during Tuesday&rsquo;s session after the company reported worse than expected fourth-quarter earnings and issued 2024 guidance.
Sophia Genetics posted GAAP loss of 37 cents per share, versus market expectations for a loss of 27 cents per share. The company&rsquo;s quarterly sales came in at $17.05 million, missing estimates of $17.33 million.
SOPHiA GENETICS shares tumbled 19% to $4.55 on Tuesday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>Sunshine Biopharma, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sbfm#NASDAQ">SBFM</a>) climbed 146.3% to $0.1106 after dipping 19% on Monday. Sunshine Biopharma recently announced closing of $10.0 million underwritten public offering.</li>
<li>Airship AI Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aisp#NASDAQ">AISP</a>) climbed 93.3% to $3.16 after the company announced that it has been awarded a contract with the Department of Justice for its Acropolis Enterprise Sensor Management video and data management platform.</li>
<li>Bruush Oral Care Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/brsh#NASDAQ">BRSH</a>) surged 42.9% to $0.0686.</li>
<li>Apogee Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/apge#NASDAQ">APGE</a>) shares jumped 41.6% to $59.10 after the company announced interim results from its Phase 1 healthy volunteer trial for APG777. Also, the company reported FY23 financial results.</li>
<li>Dave Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dave#NASDAQ">DAVE</a>) gained 39.8% to $30.62 after the company reported a year-over-year increase in fourth-quarter revenue results.</li>
<li>CareMax, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cmax#NASDAQ">CMAX</a>) rose 38.1% to $10.65.</li>
<li>Enviva Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/eva#NYSE">EVA</a>) gained 26.4% to $0.6571.</li>
<li>AeroVironment, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/avav#NASDAQ">AVAV</a>) shares surged 24.8% to $163.05 after the company reported better-than-expected results for its fourth quarter. The company said it sees FY24 adjusted earnings of $2.69 to $2.83 per share on revenue of $700 million to $710 million.</li>
<li>INNOVATE Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vate#NASDAQ">VATE</a>) rose 24.4% to $0.90. The company reported fourth quarter financial results.</li>
<li>Ocean Biomedical, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ocea#NASDAQ">OCEA</a>) climbed 24.3% to $5.07.</li>
<li>Paymentus Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pay#NYSE">PAY</a>) rose gained 20.3% to $19.67 after the company reported better-than-expected fourth quarter financial results.</li>
<li>BeyondSpring Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bysi#NASDAQ">BYSI</a>) gained 20.1% to $1.97.</li>
<li>bioAffinity Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/biaf#NASDAQ">BIAF</a>) climbed 19.4% to $2.83. bioAffinity Technologies reported accelerating sales growth of CyPath&reg; Lung.</li>
<li>XORTX Therapeutics Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xrtx#NASDAQ">XRTX</a>) gained 18.4% to $4.18.</li>
<li>Cardio Diagnostics Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cdio#NASDAQ">CDIO</a>) rose 17.9% to $1.52 after the company announced that the U.S. Patent and Trademark Office issued a notice of allowance for U.S. Application No. 17,857,723 Titled Compositions And Methods For Detecting Predisposition To Cardiovascular Disease.</li>
<li>Phunware, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/phun#NASDAQ">PHUN</a>) shares rose 17.2% to $14.56. Phunware shares jumped 75% on Monday amid volatility in Trump-related stocks after Donald Trump won the Missouri and Idaho Republican caucuses. Also, the Supreme Court ruled that Colorado can&#39;t remove Donald Trump from the Republican primary ballot in the state.</li>
<li>3D Systems Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ddd#NYSE">DDD</a>) jumped 14.7% to $4.7150. 3D Systems announced additional partial repurchase of convertible senior notes.</li>
<li>Fresenius Medical Care AG (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fms#NYSE">FMS</a>) gained 12.2% to $20.95. Fresenius Medical Care achieved next milestone in portfolio optimization program, announcing sale of dialysis clinics in Brazil, Colombia, Chile, Ecuador.</li>
<li>New York Community Bancorp, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nycb#NASDAQ">NYCB</a>) gained 11.3% to $3.0411 after falling 23% on Monday. New York Community Bancorp last week announced that it identified material weaknesses in its internal controls and replaced its CEO.</li>
<li>Vicarious Surgical Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rbot#NYSE">RBOT</a>) rose 7.8% to $0.3880 after the company reported quarterly financial results.</li>
<li>DaVita Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dva#NYSE">DVA</a>) gained 7.4% to $135.14. DaVita entered into agreement to expand operations in Brazil and Colombia, enter Chile and Ecuador.</li>
<li>Momentus Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mnts#NASDAQ">MNTS</a>) shares rose 7% to $0.8345 after the company was awarded a contract from NASA.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Quoin Pharmaceuticals, Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qnrx#NASDAQ">QNRX</a>) shares fell 46.2% to $1.56 after the company announced the pricing of a $6.5 million public offering.</li>
<li>Crawford &amp; Company (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/crd-a#NYSE">CRD-A</a>) fell 27.7% to $9.04 after the company reported worse-than-expected fourth-quarter financial results.</li>
<li>Ekso Bionics Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ekso#NASDAQ">EKSO</a>) fell 24.8% to $1.58 after the company reported mixed fourth-quarter financial results.</li>
<li>ThredUp Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tdup#NASDAQ">TDUP</a>) fell 23.3% to $1.8099 after reporting fourth-quarter results.</li>
<li>Lipella Pharmaceuticals Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lipo#NASDAQ">LIPO</a>) fell 22.5% to $0.7909. Lipella Pharmaceuticals announced FDA clearance of IND for LP-410 for oral graft-versus-host disease, advancing clinical pipeline.</li>
<li>Kineta, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ka#NASDAQ">KA</a>) fell 21% to $0.7983.</li>
<li>Eyenovia, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/eyen#NASDAQ">EYEN</a>) dipped 21% to $1.8006.</li>
<li>Semrush Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/semr#NYSE">SEMR</a>) fell 19.9% to $10.42 after the company reported fourth-quarter financial results.</li>
<li>BitFuFu Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fufu#NASDAQ">FUFU</a>) fell 19.3% to $10.60. BitFuFu shares jumped around 106% on Monday amid volatility following the company&#39;s recent business combination with Arisz Acquisition Corp and listing on the Nasdaq.</li>
<li>GitLab Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gtlb#NASDAQ">GTLB</a>) shares fell 19.2% to $60.16 after the company issued FY25 earnings guidance below estimates.</li>
<li>Sidus Space, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sidu#NASDAQ">SIDU</a>) declined 19.2% to $4.58.</li>
<li>Yiren Digital Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/yrd#NYSE">YRD</a>) fell 16.3% to $4.60.</li>
<li>Cara Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cara#NASDAQ">CARA</a>) fell 16.2% to $0.8375 following downbeat fourth-quarter results.</li>
<li>Stitch Fix, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sfix#NASDAQ">SFIX</a>) shares dipped 15.7% to $2.7650 after the company reported worse-than-expected second-quarter financial results and issued a weak revenue forecast for FY24.</li>
<li>Lotus Technology Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lot#NASDAQ">LOT</a>) fell 15.6% to $5.66.</li>
<li>Zhongchao Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zcmd#NASDAQ">ZCMD</a>) fell 13.8% to $ 2.73.</li>
<li>CECO Environmental Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ceco#NASDAQ">CECO</a>) dipped 13.8% to $19.74 despite better-than-expected fourth-quarter financial results and raised guidance.</li>
<li>Renalytix Plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rnlx#NASDAQ">RNLX</a>) shares declined 13.5% to $1.27. Renalytix shares jumped 41% on Monday after the company announced that it received an unsolicited approach from a publicly listed strategic diagnostics company.</li>
<li>Powell Industries, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/powl#NASDAQ">POWL</a>) tumbled 12.4% to $161.88.</li>
<li>Vivakor, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vivk#NASDAQ">VIVK</a>) shares fell 12.3% to $0.93 after jumping around 30% on Monday. Vivakor signed a definitive merger agreement with Empire Diversified Energy for a combined enterprise value of approximately $250 million.</li>
<li>MicroStrategy Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mstr#NASDAQ">MSTR</a>) shares declined 12.1% to $1,172.93 after the company announced a proposed private offering of $600 million of convertible senior notes.</li>
<li>AxoGen, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/axgn#NASDAQ">AXGN</a>) fell 12.1% to $9.31 following fourth-quarter financial results.</li>
<li>MingZhu Logistics Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ygmz#NASDAQ">YGMZ</a>) shares fell 11.2% to $0.4785 after gaining over 12% on Monday. MingZhu Logistics Holdings signed a non-binding letter of intent (LOI) to acquire driverless auto technologies and intellectual property (IP) portfolio valued between $80 million and $90 million.</li>
<li>Albemarle Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/alb#NYSE">ALB</a>) shares fell 11.9% to $117.40 after the company announced a proposed public offering of depositary shares.</li>
<li>Tandem Diabetes Care, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tndm#NASDAQ">TNDM</a>) dipped 11% to $27.73 after the company announced a proposed $250 million private placement of convertible notes due 2029.</li>
<li>Amer Sports, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/as#NYSE">AS</a>) fell 10.1% to $15.59 after the company reported worse-than-expected fourth-quarter adjusted EPS results and issued FY24 EPS guidance below estimates.</li>
<li>Ainos, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aimd#NASDAQ">AIMD</a>) shares fell 9.8% to $1.28 after surging 35% on Monday.</li>
<li>Samsara Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/iot#NYSE">IOT</a>) fell 9% to $32.65.</li>
<li>MongoDB, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mdb#NASDAQ">MDB</a>) fell 8.2% to $ 402.84.</li>
<li>Sprout Social, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/spt#NASDAQ">SPT</a>) fell 8% to $58.96.</li>
<li>e.l.f. Beauty, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/elf#NYSE">ELF</a>) declined 7.5% to $193.29.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/24/03/37481565/top-5-materials-stocks-that-are-ticking-portfolio-bombs"> Top 5 Materials Stocks That Are Ticking Portfolio Bombs </a>

AIMD

AISP

APGE

AVAV

AXGN

BIAF

BRSH

BYSI

CARA

Cardio Diagnostics Holdings Inc. - Common stock

CDIO

CECO

CMAX

CRD-A

DAVE

EKSO

EYEN

FUFU

LIPO

MNTS

MSTR

OCEA

PHUN

POWL

QNRX

RBOT

RNLX

SBFM

SEMR

SIDU

SOPH

TDUP

TNDM

VATE

VIVK

XRTX

YGMZ

ZCMD

Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

U.S. stocks were lower, with the Dow Jones index falling more than 200 points on Tuesday.
Shares of NIO Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nio#NYSE">NIO</a>) rose during Tuesday&rsquo;s session following <a href="https://www.benzinga.com/news/earnings/24/03/37477000/nio-surpasses-q4-earnings-expectations-eyes-growth-with-new-electric-flagship-launch">upbeat quarterly results</a>.
NIO reported fourth-quarter revenue of 17.10 billion yuan ($2.41 billion), up by 6.5% year-over-year and down by 10.3% from the previous quarter. Analysts, on average, estimated revenue of $2.29 billion for the quarter. Excluding share-based compensation expenses, the company reported an adjusted loss of (2.81) yuan or ($0.39) compared to (3.07) yuan in the year-ago quarter and (2.28) yuan in the third quarter of 2023. Analysts had called for a loss of $(0.51) per share.
NIO shares gained 3.6% to $5.52 on Tuesday.
Here are some other big stocks recording gains in today&rsquo;s session.
<ul>
<li>Apogee Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/apge#NASDAQ">APGE</a>) shares gained 41.6% to $59.10 after the company announced interim results from its Phase 1 healthy volunteer trial for APG777. Also, the company reported FY23 financial results.</li>
<li>Dave Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dave#NASDAQ">DAVE</a>) surged 39.8% to $30.62 after the company reported a year-over-year increase in fourth-quarter revenue results.</li>
<li>AeroVironment, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/avav#NASDAQ">AVAV</a>) shares climbed 24.8% to $163.05 after the company reported better-than-expected results for its fourth quarter. The company said it sees FY24 adjusted earnings of $2.69 to $2.83 per share on revenue of $700 million to $710 million.</li>
<li>Paymentus Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pay#NYSE">PAY</a>) rose 20.3% to $19.67 after the company reported better-than-expected fourth quarter financial results.</li>
<li>3D Systems Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ddd#NYSE">DDD</a>) climbed 14.7% to $4.7150. 3D Systems announced additional partial repurchase of convertible senior notes.</li>
<li>Fresenius Medical Care AG (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fms#NYSE">FMS</a>) rose 12.2% to $20.95. Fresenius Medical Care achieved next milestone in portfolio optimization program, announcing sale of dialysis clinics in Brazil, Colombia, Chile, Ecuador.</li>
<li>Krystal Biotech, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/krys#NASDAQ">KRYS</a>) gained 11.6% to $178.44.</li>
<li>New York Community Bancorp, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nycb#NASDAQ">NYCB</a>) climbed 11.3% to $3.0411 after falling 23% on Monday. New York Community Bancorp last week announced that it identified material weaknesses in its internal controls and replaced its CEO.</li>
<li>Spyre Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/syre#NASDAQ">SYRE</a>) gained 11.3% to $38.92. Spyre Therapeutics recently reported a year-over-year increase in fourth-quarter EPS results.</li>
<li>The RealReal, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/real#NASDAQ">REAL</a>) rose 10.7% to $3.5450.</li>
<li>V2X, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/vvx#NYSE">VVX</a>) gained 10.4% to $42.66 after the company reported better-than-expected fourth-quarter results and provided upbeat FY24 guidance.</li>
<li>Scholar Rock Holding Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/srrk#NASDAQ">SRRK</a>) rose 10.3% to $16.94.</li>
<li>Riskified Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rskd#NYSE">RSKD</a>) gained 8.8% to $ 4.97 after the company reported better-than-expected fourth-quarter EPS and revenue but issued guidance below estimates.</li>
<li>DaVita Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dva#NYSE">DVA</a>) rose 7.4% to $135.14. DaVita entered into agreement to expand operations in Brazil and Colombia, enter Chile and Ecuador.</li>
<li>Constellation Energy Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ceg#NASDAQ">CEG</a>) gained 4.9% to $184.63. On Monday, UBS maintained a Buy rating on the stock and raised its price target from $151 to $201.</li>
<li>Harley-Davidson, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hog#NYSE">HOG</a>) rose 4% to $38.14. DA Davidson analyst Brandon Rolle reiterated Harley-Davidson with a Buy and maintained a $42 price target.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/markets/cryptocurrency/24/03/37458044/bitcoin-surpasses-65-000-pepe-emerges-as-top-gainer"> Bitcoin Surpasses $65,000; Pepe Emerges As Top Gainer</a>

KRYS

REAL

RSKD

SRRK

SYRE

NIO Reports Upbeat Earnings, Joins Dave, V2X, Riskified And Other Big Stocks Moving Higher On Tuesday

Goldman Sachs analyst Will Nance maintains Paymentus Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PAY#NYSE">PAY</a>) with a Neutral and raises the price target from $18 to $20.

Goldman Sachs Maintains Neutral on Paymentus Holdings, Raises Price Target to $20

Shares of Paymentus Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pay#NYSE">PAY</a>) rose sharply in today&rsquo;s pre-market trading after the company reported better-than-expected fourth quarter financial results.
Paymentus reported quarterly earnings of 11 cents per share which beat the analyst consensus estimate of 7 cents per share. Quarterly sales clocked in at $164.8 million which beat the analyst consensus estimate of $157.416 million.
Paymentus Holdings shares jumped 18.3% to $19.34 in pre-market trading
Here are some other stocks moving in pre-market trading.
<h3>Gainers</h3>
<ul>
<li>Zhongchao Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zcmd#NASDAQ">ZCMD</a>) gained 79.8% to $5.70 in pre-market trading. Zhongchao recently announced a 1-for-10 share consolidation.</li>
<li>Momentus Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mnts#NASDAQ">MNTS</a>) shares rose 46.2% to $1.14 in pre-market trading after the company was awarded a contract from NASA.</li>
<li>Phunware, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/phun#NASDAQ">PHUN</a>) shares rose 30.2% to $16.16 in pre-market trading. Phunware shares jumped 75% on Monday amid volatility in Trump-related stocks after Donald Trump won the Missouri and Idaho Republican caucuses. Also, the Supreme Court ruled that Colorado can&#39;t remove Donald Trump from the Republican primary ballot in the state.</li>
<li>Sunshine Biopharma, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sbfm#NASDAQ">SBFM</a>) gained 19.3% to $0.0536 in pre-market trading after dipping 19% on Monday. Sunshine Biopharma recently announced closing of $10.0 million underwritten public offering.</li>
<li>AeroVironment, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/avav#NASDAQ">AVAV</a>) shares surged 19.1% to $155.50 in pre-market trading after the company reported better-than-expected results for its fourth quarter. The company said it sees FY24 adjusted earnings of $2.69 to $2.83 per share on revenue of $700 million to $710 million.</li>
<li>Vicarious Surgical Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rbot#NYSE">RBOT</a>) rose 15.2% to $0.4149 in pre-market trading after the company reported quarterly financial results.</li>
<li>NKGen Biotech, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nkgn#NASDAQ">NKGN</a>) climbed 13.5% to $0.9480 in pre-market trading. NKGen Biotech will present data on SNK01 in Alzheimer&#39;s disease at the Tau2024 Global Conference Mar. 25-26.</li>
<li>China Jo-Jo Drugstores, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cjjd#NASDAQ">CJJD</a>) shares gained 12.8% to $3.00 in pre-market trading after declining 9% on Monday. China Jo-Jo Drugstores recently announced a 1-for-20 reverse stock split.</li>
<li>New York Community Bancorp, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nycb#NASDAQ">NYCB</a>) gained 6.3% to $2.90 in pre-market trading after falling 23% on Monday. New York Community Bancorp last week announced that it identified material weaknesses in its internal controls and replaced its CEO.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Quoin Pharmaceuticals, Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qnrx#NASDAQ">QNRX</a>) fell 28.3% to $2.08 in pre-market trading. Quoin Pharmaceuticals shares gained over 3% on Monday after the company announced FDA clearance to recruit teen subjects into both of its ongoing Netherton Syndrome clinical studies.</li>
<li>GitLab Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gtlb#NASDAQ">GTLB</a>) shares tumbled 22.4% to $57.80 after the company issued FY25 earnings guidance below estimates.</li>
<li>Ekso Bionics Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ekso#NASDAQ">EKSO</a>) fell 17.6% to $1.73 pre-market trading after the company reported mixed fourth-quarter financial results.</li>
<li>Cara Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cara#NASDAQ">CARA</a>) fell 16.7% to $0.8325 in pre-market trading following downbeat fourth-quarter results.</li>
<li>Renalytix Plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rnlx#NASDAQ">RNLX</a>) shares declined 15% to $1.25 in pre-market trading. Renalytix shares jumped 41% on Monday after the company announced that it received an unsolicited approach from a publicly listed strategic diagnostics company.</li>
<li>Stitch Fix, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sfix#NASDAQ">SFIX</a>) shares dipped 14.5% to $2.80 in pre-market trading after the company reported worse-than-expected second-quarter financial results and issued a weak revenue forecast for FY24.</li>
<li>Ainos, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aimd#NASDAQ">AIMD</a>) shares fell 12.5% to $1.24 in pre-market trading after surging 35% on Monday.</li>
<li>Vivakor, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vivk#NASDAQ">VIVK</a>) shares fell 11.4% to $0.9397 in pre-market trading after jumping around 30% on Monday. Vivakor signed a definitive merger agreement with Empire Diversified Energy for a combined enterprise value of approximately $250 million.</li>
<li>Ethereal Tech PTE. Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fufu#NASDAQ">FUFU</a>) shares declined 11.4% to $11.62 in pre-market trading. BitFuFu shares jumped around 106% on Monday amid volatility following the company&#39;s recent business combination with Arisz Acquisition Corp and listing on the Nasdaq.</li>
<li>MingZhu Logistics Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ygmz#NASDAQ">YGMZ</a>) shares fell 10.9% to $0.48 in pre-market trading after gaining over 12% on Monday. MingZhu Logistics Holdings signed a non-binding letter of intent (LOI) to acquire driverless auto technologies and intellectual property (IP) portfolio valued between $80 million and $90 million.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/03/37474323/stitch-fix-target-and-3-stocks-to-watch-heading-into-tuesday"> Stitch Fix, Target And 3 Stocks To Watch Heading Into Tuesday</a>

CJJD

NKGN

Why Paymentus Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket

Paymentus shares are trading higher after the company reported better-than-expected Q4 financial results.

After soaring to record highs last week, traders are taking a wait-and-see approach as they anticipate a series of upcoming market-moving events.&nbsp;<a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/24/03/37464820/stocks-stall-magnificent-7-crack-as-apple-tesla-and-google-face-headwinds-bitcoin-g" rel="noreferrer noopener">Following Monday&#8217;s pullback</a>, stock futures are trading slightly down on Tuesday morning, with mega-cap tech leading the decline.
Analysts suggest this pre-market weakness may reflect traders taking profits ahead of key events this week, including Federal Reserve Chair Jerome Powell&#8216;s Congressional testimony.
Cues From Monday&#8217;s Session:
Stocks reversed course on Monday, with concerns about overbought conditions prompting investors to exercise caution.
The major averages opened lower and remained mostly flat throughout the day, except for a brief rally in late afternoon trading.
The S&amp;P 500 and the Nasdaq Composite retreated from their all-time highs, while small-cap stocks in the Russell 2,000 Index showed stronger resilience, only declining in late trading.
Defensive sectors like utilities and real estate led the gains, while communication services, consumer discretionary, and energy stocks faced significant selling pressure.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Index</td>
<td>Performance (+/-)</td>
<td>Value</td>
</tr>
<tr>
<td>Nasdaq Composite</td>
<td>-0.41%</td>
<td>16,207.51</td>
</tr>
<tr>
<td>S&amp;P 500 Index</td>
<td>-0.12%</td>
<td>5,130.95</td>
</tr>
<tr>
<td>Dow Industrials</td>
<td>-0.25%</td>
<td>38,989.83</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>-0.10%</td>
<td>2,074.31</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption"> Analyst Color:</figcaption></figure>
A fund manager on Monday reaffirmed his bullish stance on equities. &#8220;While some investors are now questioning the strength across so many market sectors, and the surprising lack of hedging for an inevitable&nbsp;correction, it is interesting to note that&nbsp;historically, when the S&amp;P is up in the first 2 months of the year, it has a positive full-year return 96% of&nbsp;the time, with an annual increase of 20.2%,&#8221; said Louis Navellier. 
&#8220;When&nbsp;a pullback comes, it seems likely that money will flow off the sidelines seeing it as a buying opportunity. The trend remains clearly positive.&#8221;
&#8220;So far, 2024 has shaped up to be similar to 1999, which was the last year when most &#8216;smid&#8217; cap stocks more than doubled,&#8221; Navellier said. &#8220;I am very hopeful that 2024 will be even better than 1999, so hang on and enjoy the ride.&#8221;
Futures Today Futures Performance On Tuesday ( as of 6 a.m. ET)
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Futures</td>
<td>Performance (+/-)</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>-0.60%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>-0.25%</td>
</tr>
<tr>
<td>Dow</td>
<td>-0.08%</td>
</tr>
<tr>
<td>R2K</td>
<td>-0.27%</td>
</tr>
</tbody>
</table>
</figure>
<a href="https://www.benzinga.com/premarket/">In premarket trading</a> on Tuesday, the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) slipped 0.25% to $511.02 and the Invesco QQQ ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) declined 0.61% to $441.32, according to <a href="https://benzinga.grsm.io/lxquj26b2sag">Benzinga Pro data.</a>
Upcoming Economic Data:
The Commerce Department is due to release its factory goods orders report for January at 10 a.m. ET. Economists, on average, call for a 3.1% month-over-month drop in factory goods orders following a 0.2% increase in December. The Commerce Department said last week durable goods, which make up the bulk of factory goods orders, fell 6.1% in January. Much of the decline was due to weak transportation orders. Excluding the volatile transportation orders, durable goods orders fell a more modest 0.3%.
S&amp;P Global&#8217;s final U.S. service sector purchasing managers&#8217; index, due at 9:45 a.m. ET, is expected at 51.4 for February versus 52.4 in January.
The Institute of Supply Management will release the results of its non-manufacturing survey for February at 10 a.m. ET. The non-manufacturing PMI is likely to come in at 53, down from 533.4 in January.
Fed Vice Chair for Supervision Michael Barr is scheduled to speak at noon ET and 3:30 p.m. ET.
See also: <a href="https://www.benzinga.com/money/best-futures-trading-software">Best Futures Trading Software</a>
Stocks In Focus:
<ul>
<li>AeroVironment, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVAV#NASDAQ">AVAV</a>) jumped over 18.5% in premarket trading following the company&#8217;s quarterly earnings announcement.</li>
<li>Among the other stocks reacting to earnings are GitLab Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTLB#NASDAQ">GTLB</a>) (down over 24%), Paymentus Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PAY#NYSE">PAY</a>) (up over 18%) and Stitch Fix, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFIX#NASDAQ">SFIX</a>) (down over 13%.</li>
<li>Target Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TGT#NYSE">TGT</a>) is due to report its quarterly results ahead of the market open, while Nordstrom, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JWN#NYSE">JWN</a>), Ross Stores, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROST#NASDAQ">ROST</a>), Box, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BOX#NYSE">BOX</a>), CrowdStrike Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) and ChargePoint Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHPT#NYSE">CHPT</a>) will report after the close.</li>
</ul>
Commodities, Bonds, Other Global Equity Markets:
Crude oil futures edged down 0.09% to $78.67 in early European session on Tuesday after the commodity fell 1.54% on Monday. The yield on the benchmark 10-year Treasury note fell 0.031 percentage points to 4.188%.
Asian stocks closed mostly lower, as they took cues from the negative close on Wall Street overnight. The Hong Kong market fell by the most, with most other markets seeing modest losses. On the other hand, the Chinese, New Zealand, and Taiwanese markets bucked the downtrend.
The major European markets showed nervousness in early trading on Tuesday.
Among the other financial markets, gold futures extended their gains to hit new highs and the cryptocurrency rally continued, led by Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>). The apex crypto is trading shy of the $67,000 level.
See Also: <a href="https://www.benzinga.com/news/large-cap/24/03/37469946/gold-breaks-above-2-110-inches-closer-to-record-high-with-rallying-mining-stocks">Gold Breaks Above $2,110, Inches Closer To Record High, With Rallying Mining Stocks</a>
Photo via Shutterstock

Futures

Previews

Economics

Federal Reserve

$BTC

Nasdaq Futures Slide On Mega-Cap Tech Weakness: Analyst Paints 1999-Like Rosy Picture, Tells Investors To 'Hang On And Enjoy The Ride'

Paymentus Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PAY#NYSE">PAY</a>) shares are climbing after the company reported its fourth-quarter financial results after the bell Monday. Here's a <a href="https://www.benzinga.com/pressreleases/24/03/b37467594/paymentus-reports-fourth-quarter-and-full-year-2023-financial-results">look at the highlights.</a>
The Details:
Paymentus reported quarterly earnings of 11 cents per share which beat the analyst consensus estimate of 7 cents per share.
Quarterly sales clocked in at $164.8 million which beat the analyst consensus estimate of $157.416 million and is a 24.68% increase over sales of $132.176 million from the same period last year.
The company processed 124.8 million transactions in the fourth quarter of 2023, an increase of 28.4% from the fourth quarter of 2022.
&#8220;Paymentus again reported quarterly results that exceeded our original expectations as revenue rose 24.7%, contribution profit grew 22.7% and adjusted EBITDA was up 95.4% year-over-year. We also ended the year on solid footing with a strong backlog, which we believe leaves us well positioned for continued growth in 2024,&#8221; said Dushyant Sharma, CEO of Paymentus Holdings.
Outlook:&nbsp;
Paymentus sees first-quarter revenue between $170 million and $176 million, versus the $177.91 million estimate and fiscal year 2024 revenue between $720 million and $744 million, versus the $732.15 million consensus estimate. 
Related News: <a href="https://www.benzinga.com/news/24/03/37461781/why-tesla-stock-is-down-more-than-6-today">Why Tesla Stock Is Down More Than 6% Today</a>
PAY Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Paymentus shares are trading up 17.9% after-hours at $19.25 at the time of publication.
Image: Pete Linforth from Pixabay

Paymentus Stock Climbs After Q4: Here's Why

Paymentus Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PAY#NYSE">PAY</a>) reported its Q4 earnings results on Monday, March 4, 2024 at 04:05 PM.
Here's what investors need to know about the announcement.
<h3>Earnings</h3>
Paymentus Holdings beat estimated earnings by 28.999999999999996%, reporting an EPS of $0.09 versus an estimate of $0.07.
Revenue was up $32.62 million from the same period last year.
<h3>Past Earnings Performance</h3>
Last quarter the company beat on EPS by $0.03 which was followed by a 7.000000000000001% increase in the share price the next day.
Here's a look at Paymentus Holdings's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2023</th>
<th>Q2 2023</th>
<th>Q1 2023</th>
<th>Q4 2022</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.04</td>
<td>0.01</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.07</td>
<td>0.08</td>
<td>0.02</td>
<td>0.02</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>152.29M</td>
<td>144.36M</td>
<td>138.13M</td>
<td>126.94M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>152.42M</td>
<td>148.94M</td>
<td>148.33M</td>
<td>132.18M</td>
</tr>
</tbody>
</table>

To track all earnings releases for Paymentus Holdings <a href="https://www.benzinga.com/quote/PAY/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Recap: Paymentus Holdings Q4 Earnings

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Paymentus Holdings Stock (NYSE:PAY), Short Interest Report

People Also Watch